These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37974923)

  • 1. Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept.
    Russell MW; Chalasani M; Rana N; Muste JC; Rachitskaya AV; Talcott KE; Singh RP; Sharma S
    J Vitreoretin Dis; 2023; 7(6):498-503. PubMed ID: 37974923
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Outcomes and Experiences with Prefilled Syringes Versus Vials for Intravitreal Administration of Anti-VEGF Treatments: A Systematic Review.
    Uzzan J; Mapani A; Cox O; Bagijn M; Saffar I
    Ophthalmol Ther; 2024 Sep; 13(9):2445-2465. PubMed ID: 39066961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes.
    Dingerkus VLS; Somfai GM; Kinzl S; Orgül SI; Becker MD; Heussen FM
    Sci Rep; 2022 Oct; 12(1):18136. PubMed ID: 36307473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents.
    Finkelstein M; Katz G; Zur D; Rubowitz A; Moisseiev E
    Ophthalmologica; 2022; 245(1):34-40. PubMed ID: 34348344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Vision Loss Associated with Prefilled Aflibercept Syringes: A Case Series and Analysis of Injection Force.
    Lee DJ; Scruggs BA; Sánchez E; Thomas M; Faridi A
    Ophthalmol Sci; 2022 Jun; 2(2):. PubMed ID: 36211641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration.
    Matsubara H; Miyata R; Kobayashi M; Tsukitome H; Ikesugi K; Kondo M
    Case Rep Ophthalmol; 2016; 7(1):230-6. PubMed ID: 27462248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of ocular hypertension after anti-VEGF injections: examining the effect of drug filtration and silicone-free syringes.
    Bae SS; Koenigstein D; Weaver T; Merkur A; Albiani D; Pakzad-Vaezi K; Kirker A
    Can J Ophthalmol; 2023 Feb; 58(1):66-72. PubMed ID: 34331870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation.
    Klaas JE; Bui V; Maierhofer N; Schworm B; Maier M; Priglinger SG; Siedlecki J
    Front Med (Lausanne); 2023; 10():1295633. PubMed ID: 37954554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure: An Analysis Using the IRIS Registry.
    Atchison EA; Wood KM; Mattox CG; Barry CN; Lum F; MacCumber MW
    Ophthalmology; 2018 May; 125(5):676-682. PubMed ID: 29336897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Incidence of Intravitreal Injection-Related Endophthalmitis With Prefilled Syringes.
    Feng HL; Abdelwahab S; Imam N; Astafurov K; Roth DB
    J Vitreoretin Dis; 2023; 7(4):305-309. PubMed ID: 37927312
    [No Abstract]   [Full Text] [Related]  

  • 11. Prefilled syringes for intravitreal injection reduce preparation time.
    Subhi Y; Kjer B; Munch IC
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.
    Mathalone N; Arodi-Golan A; Sar S; Wolfson Y; Shalem M; Lavi I; Geyer O
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1435-40. PubMed ID: 22434210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration.
    Kähkönen M; Tuuminen R; Aaltonen V
    BMC Ophthalmol; 2021 Aug; 21(1):312. PubMed ID: 34454473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures.
    Souied E; Nghiem-Buffet S; Leteneux C; Bayer S; Derveloy A; Sagkriotis A; Becker G; Cohen SY
    Eur J Ophthalmol; 2015; 25(6):529-34. PubMed ID: 26044375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Prefilled Syringes and Masking on Postintravitreal Injection Endophthalmitis.
    Louis AM; Ali AM; Patel SB; Fan KC; Rahman EZ; Pearce WA; Trejo Corona S; Villanueva Boone C; Yu HJ; Wykoff CC
    J Vitreoretin Dis; 2023; 7(5):382-388. PubMed ID: 37706081
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy.
    Aref AA
    Curr Opin Ophthalmol; 2012 Mar; 23(2):105-10. PubMed ID: 22249237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.
    Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.
    Good TJ; Kimura AE; Mandava N; Kahook MY
    Br J Ophthalmol; 2011 Aug; 95(8):1111-4. PubMed ID: 20702430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
    Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.